Jump Financial LLC Decreases Position in Henry Schein, Inc. (NASDAQ:HSIC)

Jump Financial LLC decreased its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 73.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,446 shares of the company's stock after selling 9,692 shares during the quarter. Jump Financial LLC's holdings in Henry Schein were worth $238,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Versant Capital Management Inc raised its stake in shares of Henry Schein by 274.6% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company's stock worth $32,000 after purchasing an additional 335 shares during the last quarter. Venturi Wealth Management LLC lifted its stake in Henry Schein by 3,347.1% during the 4th quarter. Venturi Wealth Management LLC now owns 586 shares of the company's stock valued at $41,000 after acquiring an additional 569 shares during the period. Quent Capital LLC boosted its holdings in shares of Henry Schein by 91.2% in the 4th quarter. Quent Capital LLC now owns 677 shares of the company's stock valued at $47,000 after acquiring an additional 323 shares during the last quarter. Smartleaf Asset Management LLC raised its holdings in shares of Henry Schein by 23.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock worth $52,000 after purchasing an additional 143 shares during the last quarter. Finally, City State Bank acquired a new position in Henry Schein during the fourth quarter valued at $55,000. Hedge funds and other institutional investors own 96.62% of the company's stock.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, Director Philip A. Laskawy sold 2,604 shares of the stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the sale, the director now directly owns 24,805 shares in the company, valued at $1,762,147.20. This represents a 9.50 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the sale, the chief executive officer now owns 62,688 shares in the company, valued at approximately $4,460,251.20. The trade was a 6.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.14% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on HSIC. UBS Group decreased their price objective on Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a report on Wednesday, February 26th. StockNews.com cut shares of Henry Schein from a "buy" rating to a "hold" rating in a research note on Thursday, April 17th. Jefferies Financial Group upped their price objective on shares of Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a research report on Thursday, January 23rd. Barrington Research reaffirmed an "outperform" rating and issued a $90.00 price target on shares of Henry Schein in a report on Wednesday, February 26th. Finally, Bank of America upgraded Henry Schein from an "underperform" rating to a "buy" rating and boosted their price objective for the company from $69.00 to $84.00 in a research report on Monday, January 6th. Six equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $80.20.

Henry Schein Trading Down 1.8 %

Henry Schein stock traded down $1.19 during trading on Wednesday, reaching $64.97. 1,059,826 shares of the company were exchanged, compared to its average volume of 1,619,316. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The stock's 50 day simple moving average is $68.73 and its two-hundred day simple moving average is $71.72. The company has a market capitalization of $7.96 billion, a P/E ratio of 26.74, a PEG ratio of 2.13 and a beta of 0.84. Henry Schein, Inc. has a 52-week low of $60.56 and a 52-week high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.04). The firm had revenue of $3.19 billion for the quarter, compared to analyst estimates of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. Henry Schein's revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.66 earnings per share. On average, equities research analysts expect that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.